Nasal Polyp Clinical Research Trial

410-931-1966 x 103

Have Asthma?

DO YOU HAVE ASTHMA?

CHESAPEAKE CLINICAL RESEARCH IN WHITE MARSH SPECIALIZES IN CONDUCTING CLINICAL RESEARCH TRIALS IN ASTHMA.

IF YOU ARE INTERESTED IN LEARNING MORE ABOUT PARTICIPATING IN A CLINICAL TRIAL FOR ASTHMA PLEASE CALL:

HANNAH

410-931-1966 EXT 113

Asthma Research Study

Need frequent rescue from your uncontrolled asthma?

Local doctors are looking for patients with uncontrolled asthma to help evaluate an investigational drug.

Living with and controlling your asthma can be a challenge. When your asthma medication doesn't help you control your symptoms, it can become frustrating, as your daily activities are interrupted or you no longer sleep soundly.

For you and others experiencing the same frustrations, local doctors are currently conducting a medical research study evaluating an investigational drug for patients who are unable to control their asthma, despite the use of asthma medication.

If you’ve been diagnosed with asthma and are struggling to control it with asthma medication, please consider learning more about this study.

Hannah McBride

410.931.1966 x 113

Have Asthma?

Protocol # CCD-05993AA3-01

You may qualify for a local ASTHMA research study now enrolling

 

POTENTIAL STUDY SUBJECT’S WILL NEED TO BE:

          -Male or female subjects aged ≥18 and ≤75 years

          - A diagnosis of asthma for at least 1 year prior to screening

          - Poorly controlled or uncontrolled moderate asthma

          - Use of a stable dose of ICS (low/medium dose) for 3 months before

            Screening visit

• Investigational ASTHMA study medication and standard of care   

   Medication for ASTHMA at no cost 

• Study-related care from a local doctor

• Compensation for travel

You may contact our office at Chesapeake Clinical Research, Inc.

(410)-931-1966 Ext 113 or visit www.chesapeakecr.com for more information.

Chiesi Farmaceutici S.p.A. Via Palermo 26/A 43122 Parma – Italy

Protocol # CCD-05993AA3-01

Principal Investigator: Dr. Jonathan Matz, M.D.